SPIROLIGOMER

Pharmaceutical products for use in oncology; Pharmaceutical products for use in dermatology treatments; pharmaceutical products for use in treatment of metabolic, cardiovascular, central nervous system, hematologic, respiratory, immunologic, inflammatory, gastrointestinal, and infectious diseases; pharmaceutical preparations for use as diagnostics

Manufacturing of synthetic, biologically active, macromolecules for others; Manufacturing of pharmaceuticals and chemicals for others

Scientific research; biomedical research services; scientific study and research in the field of the development of future medical treatments in the field of oncology, metabolic diseases, cardiovascular diseases, central nervous system diseases, dermatologic conditions, hematologic conditions, respiratory diseases, immunologic diseases, inflammatory diseases, gastrointestinal diseases, infectious diseases, and diagnostic preparations; laboratory research services in the field of oncology, metabolic diseases, cardiovascular diseases, central nervous system diseases, dermatologic conditions, hematologic conditions, respiratory diseases, immunologic diseases, inflammatory diseases, gastrointestinal diseases, infectious diseases, and diagnostic preparations; providing information, consultancy and advisory services relating to the design, planning and implementation of scientific and clinical research for others